Close Menu

Grants

Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Type $ Amount Activity Investigator Unit Sponsorsort descending Date
A Phase 2, Multi-Center, Open-Label Study to Evaluate Long-term Safety and Efficacy of CXA-10 in Subjects with Pulmonary Arterial Hypertension on Stable Background Therapy: Extension to Study CXA-10-3 Contract $80,418.76 Clinical Trial Franz Rischard Medicine Complexa, Inc. 01/2020
The Automated Diseases Activity Monitoring System (ADAMS) Contract $824,548.00 Research - Industry (62.5% MTDC) Frederic Zenhausern COM Phx NanoBioscience & Med Costa Devices Limited 10/2020
A Phase III, Multicenter, Open-Label, Extension Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI... Contract $432,030.00 Clinical Trial Ramachandra Sista COM Phx Internal Medicine Covance, Incorporated 06/2020
A Phase III Multicenter Open-Label Randomized Trial to Evaluate Efficacy and Safety of FOLFIRINOX (FFX) versus Combination of CPI-613 with modified FOLFIRINOX (mFFX) in Patients with Metastatic... Contract $297,912.00 Clinical Trial Rachna Shroff Cancer Center Division Covance, Incorporated 05/2020
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects with Idiopathic Pulmonary Fibrosis (IPF) Contract $607,532.16 Clinical Trial Sachin Chaudhary Medicine Covance, Incorporated 08/2020
A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Enzastaurin Plus R-CHOP Versus R-CHOP in Treatment-Naive Subjects with High-Risk Diffuse Large B-Cell Lymphoma Who Possess the Novel.. Contract $327,830.00 Clinical Trial Abhijeet Kumar Cancer Center Division Covance, Incorporated 01/2020
A Phase 1/2 Dose Escalation and Dose Expansion Study of BA3011 in Patients with Advanced Solid Tumors Contract $424,465.24 Clinical Trial Pavani Chalasani Cancer Center Division Covance, Incorporated 09/2020
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Ifetroban in Patients with Diffuse Cutaneous Systemic Sclerosis or Systemic Sclerosis-Associated... Contract $55,928.00 Clinical Trial Chian Kwoh Arthritis Center-Research Cumberland Pharmaceuticals, Incorporated 07/2020
A Phase Ib/II Study of Leronlimab (PRO 140) Combined with Carboplatin in Patients with CCR5+ Metastatic Triple-Negative Breast Cancer (mTNBC) Contract $122,212.50 Clinical Trial Sima Ehsani Chimeh Cancer Center Division CytoDyn Inc. 10/2020
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects with Heart Failure with Reduced Ejection Fraction... Contract $105,851.40 Clinical Trial Aaron Wolfson Sarver Heart Center Cytokinetics, Incorporated 09/2020
OHPEN (Oral Health Prevention and EducatioN) Wide Program Grant $25,000.00 Other Sponsored Activity Myra Muramoto Family and Community Medicine Delta Dental of Arizona Foundation 03/2020
A Randomized, Double-blind, Placebo-controlled Clinical Trial of Fluconazole as Early Empiric Treatment of Coccidioidomycosis Pneumonia (Valley Fever) in Adults Presenting with Community Acquired... Contract $593,373.00 Clinical Trial John Galgiani Valley Fever Ctr for Excellnc Duke University 06/2020
Introducing Palliative Care (PC) within the Treatment of End Stage Liver Disease (ESLD): A Cluster Randomized Controlled Trial. Contract $662,300.00 Clinical Trial Rohit Nathan COM Phx Internal Medicine Duke University 10/2020
Rapid Immunoassay for Diagnosis of Coccidioidomycosis Contract $49,999.00 Research John Galgiani Valley Fever Ctr for Excellnc DxDiscovery 09/2020
A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair with the Edwards PASCAL Transcatheter ...... Contract $141,792.00 Clinical Trial Ashish Pershad COM Phx Internal Medicine Edwards Lifesciences LLC 06/2020
Examining Global Gene Expression in Skin Biopsies from People with Hypermobile EDS Grant $69,020.00 Research Christina Laukaitis Medicine Ehlers-Danlos Society 03/2020
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3819253 in Participants with Mild to Moderate COVID-19 Illness Contract $1,003,039.00 Clinical Trial Jarrod Mosier Dept of Emergency Medicine Eli Lilly and Company 09/2020
Endometriosis, Infertility, and Risk of Stroke Grant $442,205.00 Research Leslie Farland Epidemiology and Biostatistics Eunice Kennedy Shriver National Institute of Child Health and Human Development 05/2020
Hormonal Response to Infant Caregiving: A Novel Strategy to Break the Opioid Relapse Cycle During The Postpartum Period Grant $2,302,500.00 Research Alicia Allen Family and Community Medicine Eunice Kennedy Shriver National Institute of Child Health and Human Development 09/2020
A Phase 1b/2 Study of AST-008 Combined with Pembrolizumab or Cemiplimab in Patients with Advanced Solid Tumors Contract $157,802.00 Clinical Trial Montaser Shaheen Cancer Center Division Exicure, Inc. 06/2020
Women Fire Fighters Study: Stress, Cancer Risk and Reproductive Toxicity Grant $1,500,000.00 Research Jefferey Burgess Community Environment & Policy Federal Emergency Management Agency 10/2020
The Crucial Role of HCN2 Channels in Inflammatory and Neuropathic Pain Contract $54,277.03 Research Rajesh Khanna Pharmacology Fondazione Cariplo (Italy) 04/2020
MIS General Surgery Fellowship Grant (AY 2021-2022) Fellowship $20,000.00 Research Training Iman Ghaderi Surgery Foundation for Surgical Fellowships 06/2020
MIS General Surgery Fellowship Grant (2020-2021) Fellowship $20,000.00 Research Training Iman Ghaderi Surgery Foundation for Surgical Fellowships 01/2020
Multi-Parametric Optimization of Software Quantification for SPECT Dopamine Transporter Imaging Contract $33,156.00 Clinical Trial Phillip Kuo Medical Imaging GE Healthcare 08/2020

Pages